These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29855563)

  • 21. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
    David FS; Stein F; Andlauer TFM; Streit F; Witt SH; Herms S; Hoffmann P; Heilmann-Heimbach S; Opel N; Repple J; Jansen A; Nenadić I; Papiol S; Heilbronner U; Kalman JL; Schaupp SK; Senner F; Schulte EC; Falkai PG; Schulze TG; Dannlowski U; Kircher T; Rietschel M; Nöthen MM; Krug A; Forstner AJ
    Schizophr Res; 2023 Feb; 252():161-171. PubMed ID: 36652833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder.
    Schulze TG; Akula N; Breuer R; Steele J; Nalls MA; Singleton AB; Degenhardt FA; Nöthen MM; Cichon S; Rietschel M; ; McMahon FJ
    World J Biol Psychiatry; 2014 Apr; 15(3):200-8. PubMed ID: 22404658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder.
    Song Y; Yang J; Chang M; Wei Y; Yin Z; Zhu Y; Zhou Y; Zhou Y; Jiang X; Wu F; Kong L; Xu K; Wang F; Tang Y
    Front Psychiatry; 2022; 13():993356. PubMed ID: 36186868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder.
    Rollins B; Martin MV; Sequeira PA; Moon EA; Morgan LZ; Watson SJ; Schatzberg A; Akil H; Myers RM; Jones EG; Wallace DC; Bunney WE; Vawter MP
    PLoS One; 2009; 4(3):e4913. PubMed ID: 19290059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.
    Girshkin L; Matheson SL; Shepherd AM; Green MJ
    Psychoneuroendocrinology; 2014 Nov; 49():187-206. PubMed ID: 25108162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease specific brain capillary angiopathy in schizophrenia, bipolar disorder, and Alzheimer's disease.
    Hirai S; Sakuma A; Kunii Y; Shimbo H; Hino M; Izumi R; Nagaoka A; Yabe H; Kojima R; Seki E; Arai N; Komori T; Okado H
    J Psychiatr Res; 2023 Jul; 163():74-79. PubMed ID: 37207434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.
    Maurer I; Zierz S; Möller HJ
    Neurobiol Aging; 2000; 21(3):455-62. PubMed ID: 10858595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics.
    Cavelier L; Jazin EE; Eriksson I; Prince J; Båve U; Oreland L; Gyllensten U
    Genomics; 1995 Sep; 29(1):217-24. PubMed ID: 8530074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis.
    Gu L; Long J; Yan Y; Chen Q; Pan R; Xie X; Mao X; Hu X; Wei B; Su L
    J Neurosci Res; 2013 May; 91(5):623-33. PubMed ID: 23404241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder.
    Andreazza AC; Wang JF; Salmasi F; Shao L; Young LT
    J Neurochem; 2013 Nov; 127(4):552-61. PubMed ID: 23692477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.
    de Sousa RT; Streck EL; Zanetti MV; Ferreira GK; Diniz BS; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
    Psychopharmacology (Berl); 2015 Jan; 232(1):245-50. PubMed ID: 24961563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.
    Aksenov MY; Tucker HM; Nair P; Aksenova MV; Butterfield DA; Estus S; Markesbery WR
    Neurochem Res; 1999 Jun; 24(6):767-74. PubMed ID: 10447460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis.
    Liu Y; Xiao X; Yang Y; Yao R; Yang Q; Zhu Y; Yang X; Zhang S; Shen L; Jiao B
    Alzheimers Dement; 2024 Jul; 20(7):4841-4853. PubMed ID: 38860751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies.
    Inam ME; Fernandes BS; Salagre E; Grande I; Vieta E; Quevedo J; Zhao Z
    Braz J Psychiatry; 2023 May; 45(4):343-55. PubMed ID: 37127280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdiagnostic time-varying dysconnectivity across major psychiatric disorders.
    Li C; Dong M; Womer FY; Han S; Yin Y; Jiang X; Wei Y; Duan J; Feng R; Zhang L; Zhang X; Wang F; Tang Y; Xu K
    Hum Brain Mapp; 2021 Mar; 42(4):1182-1196. PubMed ID: 33210798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls.
    Morisano D; Wing VC; Sacco KA; Arenovich T; George TP
    Am J Addict; 2013 Jan; 22(1):46-53. PubMed ID: 23398226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder.
    Soontornniyomkij B; Everall IP; Chana G; Tsuang MT; Achim CL; Soontornniyomkij V
    J Affect Disord; 2011 Oct; 133(3):646-54. PubMed ID: 21612826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Gray Matter Volume in Orbitofrontal Cortex Across Schizophrenia, Major Depressive Disorder, and Bipolar Disorder: A Comparative Imaging Study.
    Yang Y; Li X; Cui Y; Liu K; Qu H; Lu Y; Li W; Zhang L; Zhang Y; Song J; Lv L
    Front Neurosci; 2022; 16():919272. PubMed ID: 35757556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
    Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M
    J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.